Pliant Therapeutics, Inc. (Nasdaq: PLRX), today announced that on September 30, 2024 it granted stock options to purchase an ...

We look forward to presenting our latest intercom solutions at NAB NY 2024,” said Gary Rosen, Vice President of Global Sales ...

Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $11.33 which represents a slight increase of $0.01 or 0.09% from the prior close of $11.32. The stock opened at $11.37 and ...

Pliant Therapeutics' stock initially surged, but has since fallen due to mixed trial results and competitive pressures. Bexotegrast showed promising results in IPF and PSC trials, but dose ...

Professional intercoms provider Pliant Technologies will highlight its new CRP-C12 Compact Radio Pack at IBC2024, Sept. 13-17 ...

Pliant Therapeutics Inc (PLRX) stock saw a modest uptick, ending the day at $12.6 which represents a slight increase of $0.73 or 6.15% from the prior close of $11.87. The stock opened at $12.18 and ...

Leerink Partners analyst Faisal Khurshid has maintained their bullish stance on PLRX stock, giving a Buy rating on September 13. Faisal ...

Piper Sandler analyst Yasmeen Rahimi maintained a Buy rating on Pliant Therapeutics (PLRX – Research Report) today and set a price target ...

SOUTH SAN FRANCISCO, Calif., Sept. 10, 2024 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel ...

The National Democratic Congress (NDC) has criticised the Ghana Police Service for allowing itself to be controlled and used ...

SOUTH SAN FRANCISCO, CA - Pliant Therapeutics, Inc. (NASDAQ:PLRX), a biopharmaceutical company, announced on Monday an update to its corporate bylaws to reflect recent changes in Delaware law. The ...

Pliant Technologies will reveal its new PHS-IEHU Miniature In-ear Headset, among several enhancements to its range of ...